143-67-9

Applied Filters:

Keyword:'143-67-9'

Showing 1-2 of 2 results for "143-67-9" within Papers

Claudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumors.

Lisa M Sullivan et al.

The American journal of surgical pathology, 36(1), 73-80 (2011-10-13)

Claudins are tight junction proteins with claudin-6 (CLDN6) expression mostly restricted to embryonic and fetal life. Previously reported gene expression microarray analysis showed an increased level of CLDN6 in atypical teratoid rhabdoid tumors (AT/RT) compared with other central nervous system

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.

Jesus San Miguel et al.

The Lancet. Oncology, 14(11), 1055-1066 (2013-09-07)

Few effective treatments exist for patients with refractory or relapsed and refractory multiple myeloma not responding to treatment with bortezomib and lenalidomide. Pomalidomide alone has shown limited efficacy in patients with relapsed multiple myeloma, but synergistic effects have been noted

Page 1 of 1